<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03891329</url>
  </required_header>
  <id_info>
    <org_study_id>TA115</org_study_id>
    <nct_id>NCT03891329</nct_id>
  </id_info>
  <brief_title>Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead</brief_title>
  <official_title>BIO|MASTER.Cor Family Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-Market Clinical Follow-up of the new Cor Family ICDs/CRT-Ds (Acticor, Rivacor) and the
      new Plexa ProMRI S DX right ventricular lead to provide post-market data and supporting
      evidence for the clinical safety and performance of the devices.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 30, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cor Family-related SADE-free rate until 3-month follow-up</measure>
    <time_frame>3 months</time_frame>
    <description>SADE-free rate related to the Cor Family ICDs/CRT-Ds</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Kaplan-Meier estimate for the Cor Family related SADE-free rate</measure>
    <time_frame>3 months, 12 months</time_frame>
    <description>Application of the Kaplan-Meier method to estimate the 3-month SADE-free rate and the 12-month SADE-free rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the Automatic LV VectorOpt test (CRT-devices only) by the investigator</measure>
    <time_frame>3 months</time_frame>
    <description>Investigator appraisal of the Overall handling of the Feature (score: Very good/good/ adequate/poor/very poor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4. Assessment of the CRT AutoAdapt feature (CRT-devices only) by the investigator</measure>
    <time_frame>3 months</time_frame>
    <description>Investigator appraisal of the overall handling of the Feature (score: Very good/good/ adequate/poor/very poor)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">127</enrollment>
  <condition>Heart Failure</condition>
  <condition>Tachyarrhythmia</condition>
  <arm_group>
    <arm_group_label>Acticor/Rivacor ICDs/CRT-Ds</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Implant of the new Cor Family ICDs and Plexa ProMRI S DX lead (if applicable). Device measurements, pre-defined programming and Adverse Event Reporting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acticor/Rivacor ICDs/CRT-Ds</intervention_name>
    <description>pre-defined device programming, measurements and follow-up schedule</description>
    <arm_group_label>Acticor/Rivacor ICDs/CRT-Ds</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Plexa S DX</intervention_name>
    <description>Implantation, measurements and follow-up schedule</description>
    <arm_group_label>Acticor/Rivacor ICDs/CRT-Ds</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Standard indication for ICD or CRT-D therapy according to clinical guidelines

          -  Planned for de novo implantation of an ICD/CRT-D, or upgrade/exchange from existing
             ICD/CRT-D or pacemaker implant

          -  Able to understand the nature of study and to provide written informed consent

          -  Willing and able to perform all follow-up visits at the study site

          -  Willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring
             concept

        Exclusion Criteria:

          -  Contraindication to ICD and CRT-D therapy

          -  Planned for implantation of a CRT-DX system

          -  For VR-T DX devices: permanent atrial tachyarrhythmia

          -  For VR-T DX devices: patients requiring atrial pacing

          -  Less than 18 years old

          -  Pregnant or breast feeding

          -  Participating in another interventional clinical investigation

          -  Life-expectancy is less than 12 months

          -  Cardiac surgical procedure planned within 12 months after implantation (including
             interventional procedures like ablation, valve replacement, heart transplant etc.).
             Procedures to occur during or prior to implantation are not exclusionary
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Steffel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsspital Zürich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simone Froemer</last_name>
    <phone>+493068905</phone>
    <phone_ext>1243</phone_ext>
    <email>cor-family@biotronik.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Silke Allgaier, Dr.</last_name>
    <phone>+493068905</phone>
    <phone_ext>1244</phone_ext>
    <email>cor-family@biotronik.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kepler Universitätsklinikum</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charité Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SRH Wald-Klinikum Gera GmbH</name>
      <address>
        <city>Gera</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SRH Zentralklinikum Suhl</name>
      <address>
        <city>Suhl</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital of Cardiology</name>
      <address>
        <city>Balatonfüred</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Semmelweis Medical University</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pauls Stradins Clinical University Hospital</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>East-Slovak Cardiology Institute (VUSCH)</name>
      <address>
        <city>Košice</city>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Inselspital - Universitätsspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Zürich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Latvia</country>
    <country>Netherlands</country>
    <country>Slovakia</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2019</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

